Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-01

FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic clindamycin phosphate and benzoyl peroxide topical product, expanding access for acne treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Benzoyl Peroxide (clindamycin phosphate and benzoyl peroxide)

Snippet

SUPPL AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)